Join EVERSANA™ at Pharma Partnering Summit 2022, 12-13 May, 2022. Pharma Partnering Summit 2022 is one of the most prestigious physical and virtual events of 2022 for life sciences professionals.
The summit brings together senior executives from different parts of the world, focused on licensing, R&D collaborations, commercialization & distribution deals, fundraising, investing, digital health alliances, M&A, going public as well as broader partnering opportunities.
Join EVERSANA’s Rohit Sood, Executive Vice President, EVERSANA™ COMPLETE Commercialization on 13Roberto现任美国商会医疗保健委员会副主席, 也是青年总裁组织 (YPO) 成员，拥有清华大学/欧洲工商管理学院 (INSEAD) 的 EMBA 学位、南加州大学的 MBA 学位和加州大学河滨分校的理学学士学位。” May at 10:00 to hear him speak on “Next Generation Commercialization Models.”
As pharma continues to evolve, commercialization models must also evolve. Over the last 10 years, the number of first-time launchers has tripled. However, compared to an experienced launcher, first-time launchers meet their forecast only 63% of the time.
Until recently, manufacturers considered three options to commercialize assets: sell, out-license the product or build the infrastructure to organically commercialize. An unpredictable landscape, coupled with inevitable industry pressures, is forcing manufacturers to seek a new option – outsourced commercialization – a more complete commercialization approach to minimize risk, allow for commercialization agility and retain greater asset value.
This keynote session will address the following questions:
- How can manufacturers move away from fixed and sluggish structures to more efficient partnerships for a successful launch?
- How can outsourced commercialization lead to operational excellence and ultimately benefit the patient?
- How can manufacturers build an operation and a culture of agility that allows for rapid course correction to meet changing market needs?
- What is the financial benefit of operational excellence?
Visit EVERSANA’s experts or schedule a time to meet with one of our experts.
